- Home
- CCK vs RGC Comparison
CCK vs RGC Comparison
Compare CCK & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCK | RGC |
|---|---|---|
| Founded | 1906 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.5B |
| IPO Year | 2003 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CCK | RGC |
|---|---|---|
| Price | $98.73 | $29.36 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $121.19 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 157.0K |
| Earning Date | 04-27-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | ★ 79.72 | N/A |
| EPS | ★ 6.38 | N/A |
| Revenue | ★ $11,665,000,000.00 | N/A |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $2.38 | N/A |
| P/E Ratio | $15.53 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $89.21 | $9.39 |
| 52 Week High | $116.62 | $950.00 |
Technical Indicators
Market Signals| Indicator | CCK | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 38.31 | 53.31 |
| Support Level | $98.41 | $21.81 |
| Resistance Level | $98.83 | $36.75 |
| Average True Range (ATR) | 2.80 | 2.16 |
| MACD | -0.57 | -0.11 |
| Stochastic Oscillator | 11.40 | 42.35 |
Price Performance
Historical ComparisonAbout CCK Crown Holdings Inc.
Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.